PDK4 Antibodies

Santa Cruz Biotechnology provides a broad selection of PDK4 monoclonal antibodies for investigating pyruvate dehydrogenase kinase 4 (PDK4) in cellular metabolism. PDK4 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDK4 is a crucial enzyme that regulates the pyruvate dehydrogenase complex, influencing the balance between carbohydrate and fat metabolism. PDK4 expression is particularly elevated in tissues undergoing metabolic stress, such as the heart and skeletal muscle. The enzyme plays a significant role in the adaptation to fasting and exercise. Understanding PDK4 function is essential for elucidating metabolic disorders and developing therapeutic strategies. Research focused on PDK4 continues to reveal important insights into cellular energy regulation and metabolic adaptation. PDK4 investigation has become increasingly relevant in studies related to diabetes, obesity, and cardiovascular diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of metabolic pathways and contribute to the development of new therapeutic approaches.